Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma.

Kelly RJ, Lee J, Bang YJ, Almhanna K, Blum Murphy M, Catenacci DVT, Chung HC, Wainberg ZA, Gibson MK, Lee KW, Bendell JC, Denlinger CS, Chee CE, Omori T, Leidner R, Lenz HJ, Chao Y, Rebelatto MC, Brohawn P, He P, McDevitt J, Sheth S, Englert JM, Ku GY.

Clin Cancer Res. 2019 Nov 1. pii: clincanres.2443.2019. doi: 10.1158/1078-0432.CCR-19-2443. [Epub ahead of print]

PMID:
31676670
2.

Negative Predictive Biomarkers in Colorectal Cancer: PRESSING Ahead.

Sundar R, Tan IBH, Chee CE.

J Clin Oncol. 2019 Nov 20;37(33):3066-3068. doi: 10.1200/JCO.19.01977. Epub 2019 Sep 24. No abstract available.

PMID:
31550189
3.

Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case series.

Alsuwaigh R, Lee J, Chan G, Chee CE, Choo SP.

J Immunother Cancer. 2019 Jun 27;7(1):162. doi: 10.1186/s40425-019-0637-6.

4.

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.

Thura M, Al-Aidaroos AQ, Gupta A, Chee CE, Lee SC, Hui KM, Li J, Guan YK, Yong WP, So J, Chng WJ, Ng CH, Zhou J, Wang LZ, Yuen JSP, Ho HSS, Yi SM, Chiong E, Choo SP, Ngeow J, Ng MCH, Chua C, Yeo ESA, Tan IBH, Sng JXE, Tan NYZ, Thiery JP, Goh BC, Zeng Q.

Nat Commun. 2019 Jun 6;10(1):2484. doi: 10.1038/s41467-019-10127-x.

5.

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors.

Hellmann MD, Kim TW, Lee CB, Goh BC, Miller WH, Oh DY, Jamal R, Chee CE, Chow LQM, Gainor JF, Desai J, Solomon BJ, Das Thakur M, Pitcher B, Foster P, Hernandez G, Wongchenko MJ, Cha E, Bang YJ, Siu LL, Bendell J.

Ann Oncol. 2019 Jul 1;30(7):1134-1142. doi: 10.1093/annonc/mdz113.

PMID:
30918950
6.

Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis.

Kim G, Tan HL, Chen E, Teo SC, Jang CJM, Ho J, Ang Y, Ngoi NYL, Chee CE, Lieske B, Shabbir A, Wang LZ, So JBY, Yong WP.

Pleura Peritoneum. 2018 Aug 29;3(3):20180118. doi: 10.1515/pp-2018-0118. eCollection 2018 Sep 1.

7.

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.

Zhao Y, Shuen TWH, Toh TB, Chan XY, Liu M, Tan SY, Fan Y, Yang H, Lyer SG, Bonney GK, Loh E, Chang KTE, Tan TC, Zhai W, Chan JKY, Chow EK, Chee CE, Lee GH, Dan YY, Chow PK, Toh HC, Lim SG, Chen Q.

Gut. 2018 Oct;67(10):1845-1854. doi: 10.1136/gutjnl-2017-315201. Epub 2018 Mar 30.

8.

Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.

Heong V, Syn NL, Lee XW, Sapari NS, Koh XQ, Adam Isa ZF, Sy Lim J, Lim D, Pang B, Thian YL, Ng LK, Wong AL, Soo RA, Yong WP, Chee CE, Lee SC, Goh BC, Soong R, Tan DSP.

Int J Cancer. 2018 May 1;142(9):1890-1900. doi: 10.1002/ijc.31091. Epub 2017 Oct 17.

9.

Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?

Chan DY, Syn NL, Yap R, Phua JN, Soh TI, Chee CE, Nga ME, Shabbir A, So JB, Yong WP.

J Gastrointest Surg. 2017 Mar;21(3):425-433. doi: 10.1007/s11605-016-3336-3. Epub 2016 Dec 15.

PMID:
27981493
10.

Current status of gene expression profiling to assist decision making in stage II colon cancer.

Chee CE, Meropol NJ.

Oncologist. 2014 Jul;19(7):704-11. doi: 10.1634/theoncologist.2013-0471. Epub 2014 May 28.

11.

Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study.

Chee CE, Ashrani AA, Marks RS, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA.

Blood. 2014 Jun 19;123(25):3972-8. doi: 10.1182/blood-2014-01-549733. Epub 2014 Apr 29.

12.

Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.

Chee CE, Krishnamurthi S, Nock CJ, Meropol NJ, Gibbons J, Fu P, Bokar J, Teston L, O'Brien T, Gudena V, Reese A, Bergman M, Saltzman J, Wright JJ, Dowlati A, Brell J.

Oncologist. 2013;18(10):1091-2. doi: 10.1634/theoncologist.2013-0255. Epub 2013 Sep 26.

13.

The role of autophagy in cancer: therapeutic implications.

Yang ZJ, Chee CE, Huang S, Sinicrope FA.

Mol Cancer Ther. 2011 Sep;10(9):1533-41. doi: 10.1158/1535-7163.MCT-11-0047. Epub 2011 Aug 30. Review.

14.

Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival.

Larsen JT, Chee CE, Lust JA, Greipp PR, Rajkumar SV.

Blood. 2011 Sep 8;118(10):2702-7. doi: 10.1182/blood-2011-03-341933. Epub 2011 Jul 12.

15.

Autophagy modulation for cancer therapy.

Yang ZJ, Chee CE, Huang S, Sinicrope F.

Cancer Biol Ther. 2011 Jan 15;11(2):169-76. doi: 10.4161/cbt.11.2.14663. Review.

16.

Targeted therapeutic agents for colorectal cancer.

Chee CE, Sinicrope FA.

Gastroenterol Clin North Am. 2010 Sep;39(3):601-13. doi: 10.1016/j.gtc.2010.08.017. Review.

17.

Training programs in blood diseases: Mayo Clinic Rochester Hematology-Oncology Fellowship Program.

Chee CE, Tan TS, Moynihan TJ, Wolanskyj AP.

Am J Hematol. 2010 Jun;85(6):447-8. doi: 10.1002/ajh.21714. No abstract available.

18.

Pitfalls in the diagnosis of primary amyloidosis.

Chee CE, Lacy MQ, Dogan A, Zeldenrust SR, Gertz MA.

Clin Lymphoma Myeloma Leuk. 2010 Jun;10(3):177-80. doi: 10.3816/CLML.2010.n.027. Review.

PMID:
20511161
19.

Amyloidosis and POEMS syndrome.

Chee CE, Dispenzieri A, Gertz MA.

Expert Opin Pharmacother. 2010 Jun;11(9):1501-14. doi: 10.1517/14656561003769874. Review.

20.

Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive-stage small cell lung cancer, N0423.

Chee CE, Jett JR, Bernath AM Jr, Foster NR, Nelson GD, Molina J, Nikcevich DA, Steen PD, Flynn PJ, Rowland KM Jr.

Cancer. 2010 May 15;116(10):2382-9. doi: 10.1002/cncr.24967.

21.

Chronic natural killer-cell lymphocytosis successfully treated with alemtuzumab.

Chee CE, Warrington KJ, Tefferi A.

Blood. 2009 Oct 15;114(16):3500-2. doi: 10.1182/blood-2009-07-233403. No abstract available.

PMID:
19833855
22.

The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma.

Chee CE, Kumar S, Larson DR, Kyle RA, Dispenzieri A, Gertz MA, Colby CL, Rajkumar SV.

Blood. 2009 Sep 24;114(13):2617-8. doi: 10.1182/blood-2009-01-198788. Epub 2009 Jul 29.

23.

Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts.

Chee CE, Steensma DP, Wu W, Hanson CA, Tefferi A.

Am J Hematol. 2008 Aug;83(8):611-3. doi: 10.1002/ajh.21192.

24.

Legionella maceachernii soft tissue infection.

Chee CE, Baddour LM.

Am J Med Sci. 2007 Nov;334(5):410-3.

PMID:
18004100
25.

Superior vena cava syndrome: an increasingly frequent complication of cardiac procedures.

Chee CE, Bjarnason H, Prasad A.

Nat Clin Pract Cardiovasc Med. 2007 Apr;4(4):226-30.

PMID:
17380168
26.

71-year-old woman with fever and altered mental status.

Chee CE, Mohr DN.

Mayo Clin Proc. 2007 Feb;82(2):237-40. No abstract available.

PMID:
17290733
27.

Cardiac hypertrophy and how it may break an athlete's heart--the Cypriot case.

Chee CE, Anastassiades CP, Antonopoulos AG, Petsas AA, Anastassiades LC.

Eur J Echocardiogr. 2005 Aug;6(4):301-7. Epub 2005 Jan 21.

PMID:
15992717
28.

Infundibular ventricular septal defect, aneurysm of the sinus of Valsalva, and bicuspid aortic valve in a caucasian male.

Anastassiades CP, Chee CE, Petsas AA.

J Am Soc Echocardiogr. 2005 Mar;18(3):268-71.

PMID:
15746718
29.

Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy.

Battah SH, Chee CE, Nakanishi H, Gerscher S, MacRobert AJ, Edwards C.

Bioconjug Chem. 2001 Nov-Dec;12(6):980-8.

PMID:
11716689

Supplemental Content

Support Center